EMEA-000408-PIP02-12
Key facts
| Invented name |
Firazyr
|
| Active substance |
icatibant
|
| Therapeutic area |
Other
|
| Decision number |
P/0282/2012
|
| PIP number |
EMEA-000408-PIP02-12
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of ACE inhibitor-induced angioedema
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Shire Orphan Therapies GmbH
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|